Gut Bacteria and Inflammation:
How LPS and the Inflammasome Connect

A sensitive gut does not always come on its own. You might also notice aching joints, poor concentration or energy that disappears halfway through the day, and it is reasonable to wonder whether these things are connected.

Sometimes they are. The gut is a busy meeting point between the outside world and your immune system, and the bacteria living there, the compounds they produce and the condition of the gut lining all shape the signals your immune cells receive. One connection involves lipopolysaccharide (LPS, a molecule on the outer surface of certain bacteria that immune cells can detect) and an immune alarm system called the inflammasome (a small protein complex inside immune cells that switches on inflammation when it senses danger).

Your gut has two jobs that pull in opposite directions. It has to absorb nutrients, and it has to control contact between the contents of the bowel and the tissues beneath the lining. The lining, its mucus layer and nearby immune cells manage that contact together, and genetics can shape the environment bacteria live in, as I described in the FUT2 gene and your gut microbiome.

That conversation runs both ways. Some bacterial products encourage immune activity and others help regulate it, which is why what a microbial community can do is usually more informative than sorting bacteria into good and bad.

LPS forms part of the outer surface of Gram-negative bacteria, which are normal members of the gut community, so its presence is not automatically a problem. What matters is its structure, how much is present and where it ends up. If an inflammatory form reaches responsive immune cells, it can put them on alert.

Different bacteria make different versions. Forms with six fatty chains, called hexa-acylated LPS (hexa meaning six), including the typical LPS made by E. coli, strongly stimulate a receptor on human immune cells that helps start an inflammatory response [1]. Other gut bacteria make LPS that produces a much weaker response, and some can interfere with the stronger signal, so a whole gut community can be far less inflammatory than E. coli LPS alone would suggest [2]. The mixture matters as much as the amount, and finding E. coli on a stool test does not mean infection.

The NLRP3 inflammasome is usually described as needing two signals. The first is priming. Immune cells such as macrophages recognise molecular patterns from microbes, LPS among them, and respond by making more NLRP3 protein and more of an inactive messenger called IL-1β [3]. The second signal is the trigger, which comes from cellular stress such as potassium leaking out of the cell, excess reactive oxygen species × Reactive Oxygen Species (ROS) Reactive oxygen species (ROS) are highly reactive molecules that are naturally produced during normal energy production in the mitochondria. In small amounts they play important roles in cell signalling and immune function. However, when ROS production becomes excessive, they can contribute to oxidative stress and damage cells if the body's antioxidant defences are unable to keep up. or damaged mitochondria × Mitochondria Mitochondria are often described as the powerhouses of the cell because they produce most of the ATP that powers your body. They convert nutrients and oxygen into usable energy that supports every organ and tissue. When mitochondrial function is impaired, symptoms such as fatigue, reduced exercise tolerance and slower recovery can occur. . Only when both occur does the inflammasome assemble and activate the messengers that coordinate inflammation.

Repeated microbial signals arriving alongside ongoing cellular stress could therefore contribute to persistent inflammation. That is a reasonable hypothesis rather than something we can observe directly.

For bacterial products to affect immune cells they need to reach a place where those cells can respond, which makes the condition of the gut barrier important. Infection, intestinal inflammation, heavy alcohol intake and some medications can impair barrier function, and when it is disrupted, bacterial products have greater access to underlying tissues and, in some circumstances, the circulation.

That does not mean everyone with bloating has an abnormally permeable gut. Bloating can arise from constipation, altered fermentation × Fermentation Fermentation is the process by which gut bacteria break down certain fibres and carbohydrates. This process produces beneficial compounds such as short-chain fatty acids, but excessive fermentation can also contribute to symptoms such as bloating and gas in some individuals. You can read more here: What Fermented Foods Really Do for Your Gut , food intolerance or increased sensitivity to normal gut activity, and how quickly things move along matters as well, as I covered in gut motility and transit time. Symptoms alone cannot tell us how well the barrier is working.

Active IL-1β and its partner IL-18 do not stay in the gut. Immune messengers signal to the brain, partly through the vagus nerve, and the result is what researchers call sickness behaviour: fatigue, poor concentration, reduced appetite and less tolerance for exertion. That response is protective during an infection, and a low-grade, continuous signal may contribute to persistent tiredness.

Mitochondria, the structures that produce much of the energy cells use, also connect energy production with inflammation. When they are stressed or damaged they can release signals that help activate the inflammasome, and experiments have shown that damaged mitochondrial DNA can be involved [4]. I explore that side in my article on mitochondria and persistent fatigue.
It is a plausible mechanism rather than a diagnosis, since iron deficiency, thyroid problems, poor sleep and many other conditions produce similar tiredness, a wider question I explored in Why Am I Tired?

The microbiome does more than supply inflammatory signals. When bacteria ferment dietary fibre they produce short-chain fatty acids × Short-Chain Fatty Acids (SCFAs) SCFAs are compounds produced by gut bacteria when they ferment dietary fibre. The three main SCFAs are acetate, propionate and butyrate. (small molecules such as butyrate × Butyrate Butyrate is a short-chain fatty acid produced when gut bacteria ferment dietary fibre. It is a major fuel source for the cells lining the colon and plays an important role in gut barrier health and inflammation regulation. that fuel the cells lining the colon and take part in communication between microbes and the body), which is one reason I wrote about why feeding your gut bacteria matters more than taking them.

Butyrate does a good deal of useful work. It is the preferred fuel for the cells lining the colon, and by keeping those cells well supplied it supports the mucus layer and the tight junctions that hold the lining together, which is part of how the gut barrier stays intact. It also helps steer the immune system towards tolerance, including by encouraging regulatory T cells that dampen unnecessary inflammation. Beyond the gut, short-chain fatty acids appear to communicate with the brain through the vagus nerve, through immune signalling and, in animal studies, by influencing microglia (the brain’s resident immune cells) and the integrity of the blood-brain barrier. Researchers are interested in these pathways for mood, cognition and neuroinflammation, although most of the evidence comes from laboratory and animal studies and human research is still developing.

No established routine clinical test tells us whether a person’s NLRP3 inflammasome is overactive. CRP measures one aspect of inflammation but cannot identify this pathway. A good microbiome test can describe the organisms present and whether they are likely to produce hexa-LPS, and it can show some of their potential activities, including the ability to produce butyrate (I cover what these tests can offer in my article on understanding microbiome testing).

Genes add another layer of context. TLR4 encodes the receptor that detects LPS, and variants in it can change how strongly immune cells respond to bacterial signals, while TNFSF15 encodes an immune messenger active in the gut lining and variants in it are associated with a higher risk of inflammatory bowel disease. These are tendencies rather than predictions, since each variant has only a modest effect and none can show that inflammation is occurring. Alongside the clinical history, these results can help build a working hypothesis without confirming inflammasome activity directly.

Blood in the stool, black tarry stools, unexplained weight loss, persistent fever or significant abdominal pain need prompt medical review.

The practical question is what deserves attention in the person in front of me. Bowel habits, dietary tolerance, sleep, medication use and recent infections all provide useful information, and for some people persistent symptoms need investigation before any dietary changes.

Inflammation is the smoke, and the gut is one place worth checking for the fire. LPS and the inflammasome help explain how that connection could work, which is a good reason to consider gut health within the wider picture while keeping assessment grounded in the person’s actual findings. I look at the broader question in Why Is My Body Inflamed?